Brian Wright is a self-described “nontraditional academic.” He says his younger self would be surprised to see him teaching at the University of Virginia’s School of Data Science, which he helped ...

Acquisition builds on UCB's 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying ...

Isabella Soares is a Senior Writer for Collider, as well as a CherryPicks-approved critic. Born in Brazil, previously based in Canada, and now residing in the UK, she is passionate about stories that ...

Viral Stanford placement claim debunked as false, but real data shows declining tech hiring and rising graduate ...

Gilead Sciences has entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology companyEQT Life Sciences ...

Alignment with the FDA across proposed study parameters of RESTORE, a 16-week registrational study evaluating NVG-291 in chronic tetraplegia.Primary endpoint will be the change from baseline in GRASSP ...

This study represents a useful finding on the social modulation of the complex repertoire of vocalizations made across a variety of strains of lab mice. The evidence supporting the claims is, at ...

KSEAB will announce the 2nd PUC results OUT, April 9, 2026, on kseab.karnataka.gov.in and karresults.nic.in. The exams were ...

PUC 2 result date and time is awaited. Follow the blog for latest updates on results, direct link and more. Karnataka 2nd PUC ...

Odds of 50 random events happening to you. Millions of Americans buy lottery tickets each year, even though most people know ...

Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Enabling Phase 3 DAYBreak CLL-306 ...